Loading...
Polymers and boron neutron capture therapy(BNCT): a potent combination
Pitto-Barry, Anaïs
Pitto-Barry, Anaïs
Publication Date
2021-03
End of Embargo
Supervisor
Rights
Open Access Article. This article is licensed under a Creative Commons Attribution 3.0 Unported Licence (https://creativecommons.org/licenses/by/3.0/).
Peer-Reviewed
Yes
Open Access status
openAccess
Accepted for publication
2021-02-08
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
Boron neutron capture therapy (BNCT) has a long history of unfulfilled promises for the treatment of aggressive cancers. In the last two decades, chemists, physicists, and clinical scientists have been coordinating their efforts to overcome practical and scientific challenges needed to unlock its full therapeutic potential. From a chemistry point of view, the two current small-molecule drugs used in the clinic were developed in the 1950s, however, they both lack some of the essential requirements for making BNCT a successful therapeutic modality. Novel strategies are currently used to design new drugs, more selective towards cancer cells and tumours, as well as able to deliver high boron contents to the target. In this context, macromolecules, including polymers, are promising tools to make BNCT an effective, accepted, and front-line therapy against cancer. In this review, we will provide a brief overview of BNCT, and its potential and challenges, and we will discuss the most promising strategies that have been developed so far.
Version
Published version
Citation
Pitto-Barry A (2021) Polymers and boron neutron capture therapy(BNCT): a potent combination. Polymer Chemistry. 12(14): 2035-2044.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article